TickerFacts.

UL Solutions Inc. (ULS): Cash & Equivalents

Annual figures by period end, from SEC filings.

$295.00M
As of 2025-12-31
$434.00M
As of 2026-06-30
$315.00M2023-12-31: $315.00M2024-12-31: $298.00M2025-12-31: $295.00M$295.00M
2023-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$295.00M-1.0%2026-02-19, Balance as of period end
2024-12-31$298.00M-5.4%2026-02-19, Balance as of period end
2023-12-31$315.00Mn/a2025-02-20, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
UL Solutions Inc. (ULS)2025-12-31$295.00M-1.0%
NeoGenomics Inc (NEO)2025-12-31$159.62M-56.5%
20/20 Biolabs, Inc. (AIDX)2025-12-31$1.03M-42.5%

Compare ULS, NEO, AIDX side by side · Screen every company in Services-Testing Laboratories ↗